HEALTHCARE
EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEMS MARKET GLOBAL FORECAST TO 2020
REPORT CODE MD 3966
EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEMS MARKET GLOBAL FORECAST TO 2020 By Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), By Application (Respiratory, Cardiac, ECPR), By Geography
REPORT OVERVIEW 1.1
OBJECTIVES OF THE STUDY
•
Extracorporeal membrane oxygenation (ECMO) systems are life supports that take over the function of the lungs or sometimes the heart, outside of a patient’s body. The procedure is the backbone of the treatment of neonatal, pediatric, and adult patients with life threatening respiratory and/or cardiac failure.
•
ECMO is most commonly used in neonatal intensive-care units for newborns with pulmonary distress. It is around 75% effective in saving the life of such newborns. Today, technological advances have led to increased research and utilization of this technology in adult patients with severe respiratory ailments as well. The number of adults for whom ECMO support is used is increasing dramatically. This was more evident during the global H1N1 pandemic, which broke out in 2009 to 2011 and tailed to 2012.
•
ECMO is used in case of respiratory failure, hypoxemia, and pulmonary edema-an abnormal build-up of fluid in the lungs, Congenital Diaphragmatic Hernia (CDH), and Primary Pulmonary Hypertension of the New-Born (PPHN)-including idiopathic PPHN, respiratory distress syndrome, group B streptococcal sepsis, and asphyxia. Although it is expensive and offered in limited settings, ECMO is likely to be increasingly used for adults in the coming years. This increase in use can be attributed to the rising incidences of cardiac diseases as well as the increasing number of cardiac surgeries and heart and lung transplants performed globally.
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
1
INTRODUCTION
•
There are three modalities of ECMO systems, namely, Veno-arterial (VA), Veno-venous (VV), and Arterio-venous (AV)-also known as extracorporeal CO2 removal (ECCO2R) system. VA ECMO provides support for both lungs and the heart. VV ECMO is a type of ECMO that provides support for lungs only. AV ECMO facilitates gas exchange, especially carbon dioxide removal, by using the patient’s own arterial pressure to pump blood through the circuit. With this mode of support, oxygenation is provided by slow ventilation of the native lungs, while CO2 removal is accomplished with the help of ECMO circuit.
1.1
1.2 •
OBJECTIVES OF THE STUDY •
To identify various types and usage patterns of ECMO across industries and analyze the complete ecosystem of the global extracorporeal membrane oxygenation systems market
•
To identify the market statistics with detailed classifications through the revenue generated by all the global players in the market
•
To understand the drivers and restraints of each market segment and sub-segment
•
To analyze key market trends with regards to modality types and applications that impact the market growth
•
To study the market with focus on emerging technologies in each application and the fastest-growing market segment
•
To segment the extracorporeal membrane oxygenation systems market by modality, application, and geography
•
To provide deep dive analysis of the market segments and value forecast for the global extracorporeal membrane oxygenation systems market between 2015 and 2020
•
To provide a comprehensive competitive landscape and market share analysis of key market players
•
To profile key market players with respect to their product offerings, recent developments, and company financials
•
To identify emerging trends and opportunities in the global extracorporeal membrane oxygenation systems market
MARKET SEGMENTATION & COVERAGE The research report categorizes the global extracorporeal membrane oxygenation systems market by modality, application, and geography. Based on modality, the market has been segmented into Veno-arterial (VA), Venovenous (VV), and Arterio-venous (AV)-also known as extracorporeal CO2 removal (ECCO2 R) system). Based on application, the market has been segmented into respiratory, cardiac, and Extra-Corporeal Cardiopulmonary Resuscitation (ECPR). The market is comprehensively analyzed at a granular level based on major geographies, including North America, Europe, Asia, and Rest of the World (RoW)-including South Central America, Middle East, and South Africa to provide in-depth information on both global and regional level. •
sales@marketsandmarkets.com
www.marketsandmarkets.com
2
INTRODUCTION
• FIGURE 1
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET SEGMENTATION & COVERAGE
•
• • •
•
• • •
• • • •
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
1.3 STAKEHOLDERS •
Respiratory Care Device Manufacturers
•
Respiratory Care Device Distributors
•
Healthcare Institutions (Hospitals, ICUs, ECMO Centres)
•
Various Research and Consulting Companies
•
Various Research Associations Related to Cardio-pulmonary Care Devices
•
Regulatory Authorities such as FDA and Insurance Providers
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
3
RESEARCH METHODOLOGY
2
RESEARCH METHODOLOGY •
MarketsandMarkets research methodology was used to arrive at the market size of the global extracorporeal membrane oxygenation systems market. In this report, the market size has been estimated using three independent ways, which was later validated and verified by in-house market research experts and external key opinion leaders. The research study involved usage of extensive secondary sources, directories, and databases, such as Factiva, Businessweek, Hoovers, and OneSource. The objective of this study is to identify and collect useful information for a technical, market-oriented, and commercial study of the global extracorporeal membrane oxygenation systems market.
•
This study lays emphasis on both primary and secondary research processes. Secondary research has been used to obtain key information about the industry’s supply chain, the value chain, and the total pool of key market players.
•
Primary sources utilized in the study include in-depth market insights acquired from physicians, registered respiratory therapists, registered nurses, perfusionists, other allied health professionals, and several industry experts. Furthermore, the information was acquired from preferred suppliers, distributors, manufacturers, service and reimbursement providers, technology developers, alliances, and organizations that are related to this industry’s value chain. In the primary research process, various sources from the supply side were thoroughly interviewed to obtain quantitative and qualitative information. Primary research was conducted to analyze and identify the segmentation types, industry trends, and key companies thriving in this market. This research also sheds light on various market dynamics, such as drivers, restraints, and upcoming opportunities. It highlights various strategies adopted by leading companies in the extracorporeal membrane oxygenation systems market.
•
After the market engineering process, which includes calculations of market statistics, market breakdown, market size estimations, market forecast, and data triangulation, extensive research was conducted to gather information and validate the authenticity of data acquired.
•
Top-down, primary, and secondary research inputs were the approaches extensively used along with several data triangulation methods to perform market estimations and forecasts for the overall market segments listed in this report.
sales@marketsandmarkets.com
www.marketsandmarkets.com
4
RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF THE EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET • FIGURE 2
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET: INTEGRATED ECOSYSTEM
•
•
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
sales@marketsandmarkets.com
www.marketsandmarkets.com
5
RESEARCH METHODOLOGY
2.2
ARRIVING AT THE EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET SIZE • FIGURE 3
ARRIVING AT THE EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET SIZE
• TOP DOWN GLOBAL RESPIRATORY CARE DEVICES MARKET Positive Airway Pressure (PAP) Devices
EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEMS MARKET
Ventilators
Oxygen Concentrators
Others
2.2% 31.0%
18.0%
6.0%
North America
Europe
Asia
RoW
South Central America
45.0%
U.S.
Germany
Japan
Canada
U.K.
Australia
Mexico
France
China
Italy
India
Spain
Singapore
Latin America Middle East Africa
Switzerland Rest of Europe (RoE)
Republic of Korea Rest of Asia-Pacific (RoA)
MACRO INDICATOR
Healthcare Expenditure (USD Million)
U.S. Japan New Zealand
18,519
India
China 81,707 Germany 94,715
Korea
106,394 France
Mexico
Spain Italy Canada U.K.
France Germany China Japan U.S.
•
639,983 432,368 354,831
157,816 U.K. 209,889 Canada 242,871 Italy 263,852
263,852 242,871 209,889
354,831 Spain
2014
157,816
(USD MILLION)
432,368 Korea 106,394 639,983 India 94,715 671,874 Mexico 81,707
New Zealand
3,162,009
671,874
3,162,009
18,519
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
6
RESEARCH METHODOLOGY
2.2.1 TOP-DOWN APPROACH •
The respiratory care devices market was estimated
•
The global respiratory care devices market was segmented into sub-types, including extracorporeal membrane oxygenation (ECMO) systems, positive airway pressure (PAP) devices, ventilators, oxygen concentrators, and others, including inhalers, masks, nebulizers, and humidifiers
•
Percentage share of extracorporeal membrane oxygenation systems in the global respiratory care devices market was identified
•
Based on the percentage split, the global extracorporeal membrane oxygenation systems market was further segmented based on regions, such as North America, Europe, Asia-Pacific, and RoW
•
The percentage share of the extracorporeal membrane oxygenation systems market in each region was derived
• FIGURE 4
TOP-DOWN APPROACH
•
•
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
7
RESEARCH METHODOLOGY
2.2.2 MACRO INDICATOR- BASED APPROACH •
Exhaustive macro-indicator study was conducted to support the research finding and analysis
•
Healthcare expenditure in all major countries was identified (Value=Conversion factor*Macro Indicator)
•
The extracorporeal membrane oxygenation (ECMO) systems market was mapped to healthcare expenditure in respective major counties of all regions
•
Market size of all the countries was summed-up to obtain regional market size and then global extracorporeal membrane oxygenation system market
TABLE 1 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET: MACRO INDICATORS, BY COUNTRY, 2014 (USD MILLION) COUNTRY
•
HEALTHCARE EXPENDITURE
U.S.
xx.x
Japan
xx.x
China
xx.x
Germany
xx.x
France
xx.x
U.K.
xx.x
Canada
xx.x
Italy
xx.x
Spain
xx.x
Korea
xx.x
India
xx.x
Mexico
xx.x
New Zealand
xx.x
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
2.3 PRICE ANALYSIS OF EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY PRODUCT COMPANY
•
AVERAGE SELLING PRICE OF THE PRODUCT
MAQUET Holding B.V. & Co. KG.
xx.x
Medtronic
xx.x
Sorin Group
xx.x
Source: Secondary Research, Primary Research, and MarketsandMarkets Analysis
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
8
RESEARCH METHODOLOGY
2.4 ASSUMPTIONS COUNTRY
HEALTHCARE EXPENDITURE
Exchange Rates
All the revenues have been provided in the globally accepted currency of United States Dollar (USD). In order to convert various currencies to USD, average historical exchange rates were used for specified years. For the historical and current exchange rates required for currency conversion purpose, the OANDA website was used.
Rounding-off
Percentages and values have been rounded-off, wherever necessary.
Base Year
2014 has been considered as the base year for this report.
Status Quo
All the macroeconomic conditions have been assumed to remain same during the forecast period.
sales@marketsandmarkets.com
www.marketsandmarkets.com
9
TABLE OF CONTENTS
1 INTRODUCTION.........................................................................................................................16 •
1.1
OBJECTIVES OF THE STUDY...........................................................................................................................................16
•
1.2
MARKET SEGMENTATION & COVERAGE.........................................................................................................................17
•
1.3 STAKEHOLDERS...............................................................................................................................................................18
2
RESEARCH METHODOLOGY.....................................................................................................19 •
2.1
INTEGRATED ECOSYSTEM OF THE EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET...................20
•
2.2
ARRIVING AT THE EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET SIZE......................................21
•
2.2.1
TOP-DOWN APPROACH................................................................................................................................22
•
2.2.2
MACRO INDICATOR- BASED APPROACH.....................................................................................................23
•
2.3
PRICE ANALYSIS OF EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY PRODUCT.................24
•
2.4 ASSUMPTIONS................................................................................................................................................................24
3
EXECUTIVE SUMMARY..............................................................................................................25
4
MARKET OVERVIEW..................................................................................................................28 •
4.1
MARKET DRIVERS AND INHIBITORS...............................................................................................................................28
•
4.2
THREATS OF ECMO.........................................................................................................................................................30
•
4.3
OPPORTUNITIES IN FUTURE...........................................................................................................................................31
5
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY.............32 •
5.1 INTRODUCTION...............................................................................................................................................................33
•
5.2 VENO-ARTERIAL..............................................................................................................................................................34
•
5.3 VENO-VENOUS................................................................................................................................................................35
•
5.4
6
ARTERIO-VENOUS (AV)....................................................................................................................................................36
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION.........38 •
6.1 INTRODUCTION...............................................................................................................................................................39
•
6.2 RESPIRATORY..................................................................................................................................................................41 •
6.2.1 NEONATES.....................................................................................................................................................42
•
6.2.2 PEDIATRIC.....................................................................................................................................................43
•
6.2.3 ADULT............................................................................................................................................................43
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
10
TABLE OF CONTENTS
•
•
7
6.3 CARDIAC..........................................................................................................................................................................43 •
6.3.1 NEONATES.....................................................................................................................................................44
•
6.3.2 PEDIATRIC.....................................................................................................................................................44
•
6.3.3 ADULT............................................................................................................................................................44
6.4
EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)..............................................................................45
•
6.4.1 NEONATES.....................................................................................................................................................46
•
6.4.2 PEDIATRIC.....................................................................................................................................................46
•
6.4.3 ADULT............................................................................................................................................................46
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY..........47 •
7.1 INTRODUCTION...............................................................................................................................................................48
•
7.2
NORTH AMERICA.............................................................................................................................................................49
•
7.2.1 U.S.................................................................................................................................................................53
•
7.2.2 CANADA.........................................................................................................................................................56
•
7.2.3 MEXICO.........................................................................................................................................................59
•
•
•
7.3 EUROPE............................................................................................................................................................................62 •
7.3.1 GERMANY......................................................................................................................................................67
•
7.3.2 U.K.................................................................................................................................................................69
•
7.3.3 FRANCE.........................................................................................................................................................72
•
7.3.4 ITALY..............................................................................................................................................................74
•
7.3.5 SPAIN.............................................................................................................................................................77
•
7.3.6 SWITZERLAND...............................................................................................................................................79
•
7.3.7
REST OF EUROPE (ROE)................................................................................................................................82
7.4
ASIA-PACIFIC (APAC)......................................................................................................................................................85
•
7.4.1 JAPAN............................................................................................................................................................90
•
7.4.2 AUSTRALIA....................................................................................................................................................93
•
7.4.3 CHINA............................................................................................................................................................96
•
7.4.4 INDIA..............................................................................................................................................................99
•
7.4.5 SINGAPORE.................................................................................................................................................102
•
7.4.6
REPUBLIC OF KOREA..................................................................................................................................104
•
7.4.7
REST OF ASIA-PACIFIC...............................................................................................................................107
7.5
REST OF THE WORLD (ROW).........................................................................................................................................109
sales@marketsandmarkets.com
www.marketsandmarkets.com
11
TABLE OF CONTENTS
8
COMPETITIVE LANDSCAPE.....................................................................................................113 •
8.1
NEW PRODUCT LAUNCH & PRODUCT DEVELOPMENT...............................................................................................114
•
8.2
AGREEMENT, ACQUISITION & PARTNERSHIP...............................................................................................................115
•
8.3 EXPANSION....................................................................................................................................................................116
•
8.4 OTHER............................................................................................................................................................................117
9
COMPANY PROFILES...............................................................................................................118 •
•
•
•
9.1
MAQUET HOLDING B.V. & CO. KG................................................................................................................................118
•
9.1.1 OVERVIEW...................................................................................................................................................118
•
9.1.2
KEY FINANCIALS.........................................................................................................................................118
•
9.1.3
PRODUCT AND SERVICE OFFERINGS.........................................................................................................119
•
9.1.4
RELATED DEVELOPMENTS..........................................................................................................................120
•
9.1.5
MNM VIEW..................................................................................................................................................121
9.2
MEDTRONIC, INC. (U.S.)...............................................................................................................................................122
•
9.2.1 OVERVIEW...................................................................................................................................................122
•
9.2.2
KEY FINANCIALS.........................................................................................................................................122
•
9.2.3
PRODUCT AND SERVICE OFFERINGS.........................................................................................................123
•
9.2.4
RELATED DEVELOPMENTS..........................................................................................................................124
•
9.2.5
MNM VIEW..................................................................................................................................................124
9.3
MICROPORT SCIENTIFIC CORPORATION......................................................................................................................125
•
9.3.1 OVERVIEW...................................................................................................................................................125
•
9.3.2
KEY FINANCIALS.........................................................................................................................................125
•
9.3.3
PRODUCT AND SERVICE OFFERINGS.........................................................................................................126
•
9.3.4
MNM VIEW..................................................................................................................................................126
9.4
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION..............................................................................................127
•
9.4.1 OVERVIEW...................................................................................................................................................127
•
9.4.2
KEY FINANCIALS.........................................................................................................................................127
•
9.4.3
PRODUCT AND SERVICE OFFERINGS.........................................................................................................128
•
9.4.4
RELATED DEVELOPMENTS..........................................................................................................................128
•
9.4.5
MNM VIEW..................................................................................................................................................128
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
12
TABLE OF CONTENTS
•
•
•
9.5
MEDOS MEDIZINTECHNIK AG.......................................................................................................................................129
•
9.5.1 OVERVIEW...................................................................................................................................................129
•
9.5.2
PRODUCT AND SERVICE OFFERINGS.........................................................................................................129
•
9.5.3
RELATED DEVELOPMENTS..........................................................................................................................130
•
9.5.4
MNM VIEW..................................................................................................................................................130
9.6
NIPRO MEDICAL CORPORATION...................................................................................................................................131
•
9.6.1 OVERVIEW...................................................................................................................................................131
•
9.6.2
KEY FINANCIALS.........................................................................................................................................131
•
9.6.3
PRODUCT AND SERVICE OFFERINGS.........................................................................................................131
•
9.6.4
RELATED DEVELOPMENTS..........................................................................................................................132
•
9.6.5
MNM VIEW..................................................................................................................................................132
9.7
SORIN GROUP (SORIN S.P.A.).......................................................................................................................................133
•
9.7.1 OVERVIEW...................................................................................................................................................133
•
9.7.2
SORIN GROUP: KEY FINANCIALS................................................................................................................133
•
9.7.3
PRODUCT AND SERVICE OFFERINGS.........................................................................................................134
•
9.7.4
RELATED DEVELOPMENTS..........................................................................................................................135
•
9.7.5
MNM VIEW..................................................................................................................................................135
10 APPENDIX................................................................................................................................136 •
10.1
INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE..............................................................................................136
•
10.2
CUSTOMIZATION OPTIONS...........................................................................................................................................137
•
•
10.2.1
PRODUCT ANALYSIS...................................................................................................................................137
•
10.2.2
PULMONOLOGIST/PHYSICIANS PERCEPTION ANALYSIS.........................................................................137
•
10.2.3
REGULATORY FRAMEWORK........................................................................................................................137
•
10.2.4
COMPETITIVE INTELLIGENCE.....................................................................................................................137
10.3
RELATED REPORTS........................................................................................................................................................138
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
13
LIST OF TABLES
• TABLE 1
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET: MACRO INDICATORS, BY COUNTRY, 2014 (USD MILLION).............................................................................23
• TABLE 2
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET: DRIVERS AND INHIBITORS................................................................................................................................28
• TABLE 3
EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................33
• TABLE 4
VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)...................................................................................................34
• TABLE 5
VENO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)...................................................................................................36
• TABLE 6
ARTERIO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY GEOGRAPHY, 2013–2020 (USD MILLION)...................................................................................................37
• TABLE 7
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)..................................................................................................40
• TABLE 8
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)............................................................................41
• TABLE 9
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)............................................................................44
• TABLE 10
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR, BY AGE GROUP, 2013-2020 (USD MILLION).....................................................................................................45
• TABLE 11
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)...................................................................................................48
• TABLE 12
NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................50
• TABLE 13
NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)..................................................................................................51
• TABLE 14
NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)................................................51
• TABLE 15
NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)........................................................52
• TABLE 16
NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)............................................................................53
• TABLE 17
U.S.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................55
• TABLE 18
U.S.: EXTRA CORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION, 2013-2020 (USD MILLION)...............................................................................................................................55
sales@marketsandmarkets.com
www.marketsandmarkets.com
14
LIST OF TABLES
• TABLE 19
CANADA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................57
• TABLE 20
CANADA: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION, 2013-2020 (USD MILLION)..................................................................................................58
• TABLE 21
MEXICO: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................60
• TABLE 22
MEXICO: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION, 2013-2020 (USD MILLION)...............................................................................................................................61
• TABLE 23
EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................63
• TABLE 24
EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION, 2013-2020 (USD MILLION)..................................................................................................63
• TABLE 25
EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)................................................64
• TABLE 26
EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)........................................................65
• TABLE 27
EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)..............................................................66
• TABLE 28
GERMANY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................68
• TABLE 29
GERMANY: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION, 2013-2020 (USD MILLION)..................................................................................................68
• TABLE 30
U.K.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................71
• TABLE 31
U.K.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)..................................................................................................71
• TABLE 32
FRANCE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................73
• TABLE 33
FRANCE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)..................................................................................................73
• TABLE 34
ITALY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................75
• TABLE 35
ITALY: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION, 2013-2020 (USD MILLION)...............................................................................................................................76
• TABLE 36
SPAIN: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................78
sales@marketsandmarkets.com
www.marketsandmarkets.com
15
LIST OF TABLES
• TABLE 37
SPAIN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)..................................................................................................78
• TABLE 38
SWITZERLAND: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................80
• TABLE 39
SWITZERLAND: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)..................................................................................................81
• TABLE 40
ROE: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................83
• TABLE 41
ROE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)..................................................................................................84
• TABLE 42
APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................86
• TABLE 43
APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)..................................................................................................86
• TABLE 44
APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)................................................87
• TABLE 45
APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)........................................................88
• TABLE 46
APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)..............................................................89
• TABLE 47
JAPAN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................91
• TABLE 48
JAPAN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)..................................................................................................92
• TABLE 49
AUSTRALIA: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................94
• TABLE 50
AUSTRALIA: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)..................................................................................................95
• TABLE 51
CHINA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).......................................................................................................97
• TABLE 52
CHINA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)..................................................................................................98
• TABLE 53
INDIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).....................................................................................................100
• TABLE 54
INDIA: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)................................................................................................101
sales@marketsandmarkets.com
www.marketsandmarkets.com
16
LIST OF TABLES
• TABLE 55
SINGAPORE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).....................................................................................................103
• TABLE 56
SINGAPORE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)................................................................................................103
• TABLE 57
REPUBLIC OF KOREA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).....................................................................................................105
• TABLE 58
REPUBLIC OF KOREA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)................................................................................................106
• TABLE 59
REST OF APAC: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).....................................................................................................108
• TABLE 60
REST OF APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)................................................................................................108
• TABLE 61
ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION).....................................................................................................109
• TABLE 62
ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)................................................................................................110
• TABLE 63
ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)..............................................111
• TABLE 64
ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)......................................................111
• TABLE 65
ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)............................................................112
• TABLE 66
EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET, BY COMPANY, 2014 (%)..................................................................................................................................113
• TABLE 67
MAQUET HOLDING B.V. & CO. KG.: KEY FINANCIALS, BY BUSINESS SEGMENT, 2012-2014 (USD MN)......................................................................................................................................118
• TABLE 68
MAQUET HOLDING B.V. & CO. KG.: KEY FINANCIALS, BY GEOGRAPHY, 2012-2014 (USD MN)......................................................................................................................................119
• TABLE 69
MEDTRONIC, INC. : KEY FINANCIALS, BY BUSINESS SEGMENT, 2012-2014 (USD MN)..............................122
• TABLE 70
MEDTRONIC, INC.: KEY FINANCIALS, BY GEOGRAPHY, 2012-2014 (USD MN).............................................123
• TABLE 71
MICROPORT SCIENTIFIC CORPORATION: KEY FINANCIALS, BY BUSINESS SEGMENT, 2012-2014 (USD MN)......................................................................................................................................126
• TABLE 72
MICROPORT SCIENTIFIC CORPORATION: KEY FINANCIALS, BY GEOGRAPHY, 2012-2014 (USD MN)......................................................................................................................................126
• TABLE 73
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: KEY FINANCIALS, BY BUSINESS SEGMENT, 2012-2014 (USD MN)............................................................................................127
sales@marketsandmarkets.com
www.marketsandmarkets.com
17
LIST OF TABLES
• TABLE 74
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: KEY FINANCIALS, BY GEOGRAPHY, 2012-2014 (USD MN)..........................................................................................................128
• TABLE 75
NIPRO MEDICAL CORPORATION: KEY FINANCIALS, BY BUSINESS SEGMENT, 2011-2014 (USD MN)......................................................................................................................................131
• TABLE 76
SORIN GROUP: KEY FINANCIALS, BY BUSINESS SEGMENT, 2013-2014 (USD MN).....................................133
• TABLE 77
SORIN GROUP: KEY FINANCIALS (CARDIAC SURGERY), BY BUSINESS SUB-SEGMENT, 2013-2014 (USD MN)......................................................................................................................................134
• TABLE 78
SORIN GROUP: KEY FINANCIALS, BY GEOGRAPHY, 2013-2014 (USD MN)...................................................134
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
18
LIST OF FIGURES
• FIGURE 1
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET SEGMENTATION & COVERAGE..........................................................................................................................17
• FIGURE 2
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET: INTEGRATED ECOSYSTEM................................................................................................................................20
• FIGURE 3
ARRIVING AT THE EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET SIZE........................21
• FIGURE 4
TOP-DOWN APPROACH....................................................................................................................................22
• FIGURE 5
MACRO INDICATOR-BASED APPROACH..........................................................................................................23
• FIGURE 6
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET SNAPSHOT..........................................27
• FIGURE 7
EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY MODALITY, 2014 & 2020 (USD MILLION)............................................................................................................................33
• FIGURE 8
VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY, 2015 & 2020 (USD MILLION)................................................................................................34
• FIGURE 9
VENO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY, 2015 & 2020 (USD MILLION)................................................................................................35
• FIGURE 10
ARTERIO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY GEOGRAPHY, 2015 & 2020 (USD MILLION)................................................................................................37
• FIGURE 11
INDICATIONS WHERE ECMO IS USED..............................................................................................................39
• FIGURE 12
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)..............................................................................................40
• FIGURE 13
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION).............................................41
• FIGURE 14
NEONATAL SURVIVAL RATE, EXTRACORPOREAL LIFE SUPPORT ORGANIZATION (ELSO) DATA (1987-1993).............................................................................................................................................42
• FIGURE 15
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION).................................................................................................43
• FIGURE 16
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR, BY AGE GROUP, 2015 & 2020 (USD MILLION).................................................................................................45
• FIGURE 17
EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO): GROWTH ANALYSIS, BY GEOGRAPHY, 2014-2020 (USD MILLION)...................................................................................................48
• FIGURE 18
NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)............................................................................................................................50
• FIGURE 19
NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION).............................................51
• FIGURE 20
NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)....................................................52
sales@marketsandmarkets.com
www.marketsandmarkets.com
19
LIST OF FIGURES
• FIGURE 21
NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)...........................................................53
• FIGURE 22
U.S.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)............................................................................................................................54
• FIGURE 23
U.S.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)...................................................................................................54
• FIGURE 24
U.S.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)..............................................................................................55
• FIGURE 25
CANADA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)............................................................................................................................56
• FIGURE 26
CANADA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)...................................................................................................57
• FIGURE 27
CANADA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)..............................................................................................58
• FIGURE 28
MEXICO: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)...............................................................................................................................................59
• FIGURE 29
MEXICO: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)...................................................................................................60
• FIGURE 30
MEXICO: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)..............................................................................................61
• FIGURE 31
EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)...............................................................................................................................................62
• FIGURE 32
EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION).............................................64
• FIGURE 33
EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)....................................................65
• FIGURE 34
EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)...........................................................66
• FIGURE 35
GERMANY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)............................................................................................................................67
• FIGURE 36
GERMANY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)...................................................................................................67
• FIGURE 37
GERMANY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)..............................................................................................68
• FIGURE 38
U.K.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)...............................................................................................................................................70
sales@marketsandmarkets.com
www.marketsandmarkets.com
20
LIST OF FIGURES
• FIGURE 39
U.K.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)...................................................................................................70
• FIGURE 40
U.K.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)..............................................................................................71
• FIGURE 41
FRANCE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)............................................................................................................................72
• FIGURE 42
FRANCE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)...................................................................................................72
• FIGURE 43
FRANCE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)..............................................................................................73
• FIGURE 44
ITALY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)...............................................................................................................................................74
• FIGURE 45
ITALY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)...................................................................................................75
• FIGURE 46
ITALY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)..............................................................................................76
• FIGURE 47
SPAIN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)...............................................................................................................................................77
• FIGURE 48
SPAIN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)...................................................................................................77
• FIGURE 49
SPAIN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)..............................................................................................78
• FIGURE 50
SWITZERLAND: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)............................................................................................................................79
• FIGURE 51
SWITZERLAND: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)...................................................................................................80
• FIGURE 52
SWITZERLAND: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)..............................................................................................81
• FIGURE 53
ROE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)...............................................................................................................................................82
• FIGURE 54
ROE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)...................................................................................................83
• FIGURE 55
ROE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)..............................................................................................84
• FIGURE 56
APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)............................................................................................................................85
sales@marketsandmarkets.com
www.marketsandmarkets.com
21
LIST OF FIGURES
• FIGURE 57
APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION).............................................87
• FIGURE 58
APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)....................................................88
• FIGURE 59
APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)...........................................................89
• FIGURE 60
JAPAN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)...............................................................................................................................................90
• FIGURE 61
JAPAN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)...................................................................................................91
• FIGURE 62
JAPAN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)..............................................................................................92
• FIGURE 63
AUSTRALIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)............................................................................................................................93
• FIGURE 64
AUSTRALIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)...................................................................................................94
• FIGURE 65
AUSTRALIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)..............................................................................................95
• FIGURE 66
CHINA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)...............................................................................................................................................96
• FIGURE 67
CHINA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)...................................................................................................97
• FIGURE 68
CHINA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)..............................................................................................98
• FIGURE 69
INDIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)...............................................................................................................................................99
• FIGURE 70
INDIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION).................................................................................................100
• FIGURE 71
INDIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)............................................................................................101
• FIGURE 72
SINGAPORE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)..........................................................................................................................102
• FIGURE 73
SINGAPORE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION).................................................................................................102
• FIGURE 74
SINGAPORE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)............................................................................................103
sales@marketsandmarkets.com
www.marketsandmarkets.com
22
LIST OF FIGURES
• FIGURE 75
REPUBLIC OF KOREA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)..........................................................................................................................104
• FIGURE 76
REPUBLIC OF KOREA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION).................................................................................................105
• FIGURE 77
REPUBLIC OF KOREA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)............................................................................................106
• FIGURE 78
REST OF APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%).............................................................................................................................................107
• FIGURE 79
REST OF APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION).................................................................................................107
• FIGURE 80
REST OF APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)............................................................................................108
• FIGURE 81
ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%).............................................................................................................................................109
• FIGURE 82
ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)...........................................110
• FIGURE 83
ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)..................................................111
• FIGURE 84
ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION).........................................................112
• FIGURE 85
EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET, BY COMPANY, 2014 (%).....................113
• FIGURE 86
MAQUET HOLDING B.V. & CO. KG.: REVENUE MIX, 2014 (%).......................................................................118
• FIGURE 87
MEDTRONIC, INC.: REVENUE MIX, 2014 (%).................................................................................................122
• FIGURE 88
MICROPORT SCIENTIFIC CORPORATION: REVENUE MIX, 2014 (%).............................................................125
• FIGURE 89
TERUMO CORPORATION: REVENUE MIX, 2014 (%).......................................................................................127
• FIGURE 90
NIPRO MEDICAL CORPORATION: REVENUE MIX, 2014 (%)...........................................................................131
• FIGURE 91
SORIN GROUP: REVENUE MIX, 2014 (%).......................................................................................................133
sales@marketsandmarkets.com
www.marketsandmarkets.com
23
SAMPLE TABLES
TABLE 1 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION) 2013
2014
2015
2020
CAGR (2014–2020)
North America
xx.x
xx.x
xx.x
xx.x
xx.x%
Europe
xx.x
xx.x
xx.x
xx.x
xx.x%
Asia-Pacific
xx.x
xx.x
xx.x
xx.x
xx.x%
RoW
xx.x
xx.x
xx.x
xx.x
xx.x%
TOTAL
xx.x
xx.x
xx.x
xx.x
xx.x%
REGION
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
TABLE 2 MEXICO: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION) 2013
2014
2015
2020
CAGR (2014–2020)
Veno-arterial (VA)
xx.x
xx.x
xx.x
xx.x
xx.x%
Veno-venous (VV)
xx.x
xx.x
xx.x
xx.x
xx.x%
Arterio-venous (AV)
xx.x
xx.x
xx.x
xx.x
xx.x%
TOTAL
xx.x
xx.x
xx.x
xx.x
xx.x%
MODALITY
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
TABLE 3 GERMANY: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION, 2013-2020 (USD MILLION) 2013
2014
2015
2020
CAGR (2014–2020)
Respiratory
xx.x
xx.x
xx.x
xx.x
xx.x%
Cardiac
xx.x
xx.x
xx.x
xx.x
xx.x%
ECPR
xx.x
xx.x
xx.x
xx.x
xx.x%
TOTAL
xx.x
xx.x
xx.x
xx.x
xx.x%
APPLICATION
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
sales@marketsandmarkets.com
www.marketsandmarkets.com
24
RELATED REPORTS
RELATED REPORTS SR. NO.
REPORT TITLE
1
FETAL (LABOR & DELIVERY) AND NEONATAL CARE EQUIPMENT MARKET Nasal CPAP, Oxygen hoods, ECMO, NO delivery units, ventilators, Fetal monitors, Capnographs, Pulse Oximeter, Vital Signs Monitors, Resuscitators - Global Trends, Competitor Analysis & Forecasts up till 2016
2
RESPIRATORY CARE DEVICES MARKET By Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables & Accessories) & by End User (Hospital, Home Care) - Global Forecast to 2020
Systems n (ECMO) e Oxygenatio eal Membran
Extracorpor
E ET ARK BRAN MEM STEMS M L A E Y R O) S RPO (ECM ACO EXTR NATION E G (AV)), 2020 OXY OUS -VEN AST TO
t To 2020
al Forecas
Market – Glob
Extracorporeal Memb rane Oxygenation (ECMO) System
s Market – Global
ket by ems mar tion syst Venone oxygena segmented into membra SE been (ECCO2 rporeal ket has removal MARKET al extraco a, the mar real CO2 the glob 1.2 and Extr modality gorizes extracorpo iac, on as cate ed card wn rt Bas -also kno graphy. arch repo respiratory, a granular The rese enous (AV) ted into , and geo lyzed at rio-v men tion ana y seg lica Arte (RoW), app ensivel been , and the World modality compreh ket has nous (VV) Rest of , the mar , Veno-ve market is on both , Asia, and PR). The rmation application arterial (VA) , Europe epth info itation (EC rica Based on . in-d usc Ame em) ide Res th R) syst onary to prov uding Nor th Africa Cardiopulm hies, incl and Sou Corporeal or geograp dle East, ed on maj rica, Mid level bas tral Ame South Cen T including level. regional TEMS MARKE global and ATION SYS
RAGE
VE TION & CO GMENTA
FIGURE 1
OXYGEN MBRANE POREAL ME EXTRACOR VERAGE TION & CO SEGMENTA
ENTATION
FOR
N APPLICATIO MODALITY
ry • Respirato • Cardiac oreal • Extracorp ary Cardiopulmon (ECPR) tion Resuscita
rial (VA) • Veno-arte ous (VV) • Veno-ven nous (AV) • Artrio-ve
Company e Papers, arch, Whit
rts, Annual Repo
2.1 FIGURE 2
2011
September 2015
Forecast To 2020
INTEGRATED ECOS YSTEM OF THE EXTRACORPOREAL OXYGENATION SYSTEMS MAR MEMBRANE KET EXTRACORPOREA L MEMBRANE OXYG ENATION SYSTEMS ECOSYSTEM MARKET: INTEG
Medical Devices Respiratory Care Devices Market
COMPANY
Extra corpor eal Me mb
rane
2. 2.
Medtronic MAQUET Holding B.V. & Co. KG. Sorin Group
Extracorporeal Membr Oxygenation System ane s Market
1
Oxyg
enation
(ECMO
) Syste
APPLICATION
TO P-
Press Rele
ms Ma rket –
D
Glob
al Fo
ORY
Air (PAP) way Pre Devic ssure es
Venti
ACOR PO ME OXYG MBRA REAL NE EN SYST ATION (EC EMS MARK MO) ET
North Americ a
18.0% 6.0%
Spain
conda
Res Euro t of pe (RoE
ry Re
search , Wh ite Pa
pers, Comp any
India
Rep )
ublic of
.com rketsa
leases
, and
rkets
U.K.
Marke
Austra lia
: Sec ond ary
Resea
rch , Wh ite
, Com
ndMa
rkets
pan
y Ann
22
ual
3,16
3,16
Repor
ts,
Centra Americ l a
Americ a East
Africa
201 4 (USD MILL
ers
2,00
2,00
9
ION)
9
Pre
ss Re
ses
, and
Ma
rke
rketsa
Latin Middle
ore
Korea
(US IND D Mil ICA lion TOR )
Analy sis
Pap
lea
© Ma
South
China India Singap Repub
Asia-P Rest acific of (RoA)
MA CRO
tsand Marke ts
Sou rce
RoW
Japan
France
lic of
tors
6.0%
Asia
Switze rland Rest Europe of (RoE)
entra
rs
18.0 %
e
Italy
U.S. 18,5 Japa Health 19 n 81,7 Chin car 07 a e Exp 94,7Germ end 15 any 106 itur 671 ,394 Fran e ,874 ce 157 639 ,816 ,983 432 209 U.K. ,368 Can ,889 354 Fran ,831 242ada 263 ,871 Germ ce ,852 263 Italy any ,852 242 Chin ,871 Spa354 a in ,831 209 Japa ,889 Kore 432 n 157 a ,368 U.S. ,816 India 106 639 ,394 Mex ,983 94,7 ico New 67115 Zeal 81,7 ,874 and 07 18,5 19
Conc
Othe
Germa ny
Spain
Zeal and Mex ico India Kore a
Spa in Italy
ada
U.K.
S
RKE T
Oxyg en
%
Europ
a
Mexico
New
Can
20
ndMa
Canad
ICE S MA
2.2%
31.0
U.S.
East
STEM
PIR ATO
EXTR ACO RPO OXY MEMBRA REA GEN L SYS ATIO NE TEM N (ECM S MAR O) KET
45.0 %
Afric a
Korea
Asia Rest of -Pac ific (Ro A)
ss Re
© Ma
Middle
N SY
WN
RES
RY CAR E DEV
rs
North Ameri ca
rica
apore
ports , Pre
BAL
ilato
Latin Ame
Sing
Annu al Re
GLO
Vent
South Central Ame rica
Chin a
Switzer land
e: Se
Posit ive Airwa (PAP ) Deviy Pres ces sure
RoW Australi a
Italy
17
MAR
Japa n
Fran ce
) Sy
ncentr ators ARRIVI
Asia
U.K.
MO
stems AR Marke RI t – Glo SYST VING bal EM AT TH Forec SM ast ARKE E EXTR To 20 NG 20 T SI ACOR KET AT THE ZE PORE SIZE EXTR AL ACOR MEM PORE BRAN AL M EMBR E OX ANE YGEN OXYG ATIO ENAT TOP N IO DO
RE 3
Others
German y
mbran e Ox
ygena tion (EC
2.2 FIGU
n Co
Europe
U.S.
rkets
orpore
al Me
KET
Oxyge
31.0%
Can ada
© MarketsandMa
Extrac
DEVI CES MAR
2.2%
Mex ico
Sourc
CARE
EXTR
lators
45.0%
ets mark and rkets Markets .ma and www © Markets
RATED
PARENT Healthcare Industry
ndary Rese
Source: Seco
September
OWN The Respiratory recas resp t To 20 AP PR irato 20 O AC ry The Cardiac care de H globa Nipro Medical vices extra l re Corporation mar corp spira ket wa orearporeal vent Extraco l mem tory ca Terumo Medica ila s es Cardiopulmona re de l Corporation timat ry hum tors, ox bran ed Resusc vices idifie itation e ox ygen MODALITY MicroPort Scientif (ECPR) ygen rs conc mar PHY ic at GRA Pe ke ion en GEO rcent Corporation t wa trato (ECM Veno-arterial (VA) age rs, s O) sy care and Medos Medizin stem segmen devic share technik AG othe of ted s, es m rs, Veno-venous (VV) rica into Base arke extraco includ positive rpor t wa d on sub-t • North Ame air ing ea s ide mar ypes the inhale way pres ntifie l mem ke , inc Artrio-venous (AVR) perce sure bran rs, • Europe d and t was fu luding mas e ox (PAP RoW rther ntage sp ific ks, ygen segm nebu ) devices lit, th • Asia-Pac ation ) (RoW The Source: d lizer en e Seconda Worl syste ted ry Research, White the pe s, an , base global ms • Rest of Papers, Compan regio rcentag d extra in th d on y Annual Reports e sh n wa co e re , Press Release globa rp ar gions s de s, and Markets rived e of th l resp , such oreal m andMarkets Analysis e ex irato FIGU as No embran traco ry RE 4 e ox rth Am rpor eal erica ygenat mem TOPion , Eu bran DOW sy rope e ox N AP , Asia- stems ygen PROA Pacif ation ic, CH syste ms mar ket in ea GLOB ch ts Analysis AL RE ndMarke Marketsa Positi SPIR ve ases, and AT
GM MARKET SE
EC
IO ARTER Y (VV), RAPH OUS EOG O-VEN ), BY G VEN PR (VA), IAC, EC RIAL D R TE A R Y, C O-A (VEN PIRATOR LITY ES ODA N (R BY M ATIO PPLIC BY A
BAL
GLO
PUBLISHED DATE
tsa
ndM
ark
ets
Ana
lysi s
21
sales@marketsandmarkets.com
www.marketsandmarkets.com
25
ABOUT MNM
MarketsandMarkets is a global market research and consulting company. It is World’s No. 2 in terms of premium market research studies published annually. Serving as a business intelligence partner to Fortune 500 companies across the world, it provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers seventeen industry verticals, including advanced materials, aerospace and defense, agriculture, automotive and transportation, biotechnology, building and construction, chemicals, energy and power, food and beverages, industrial automation, medical devices, mining, minerals and metals, packaging, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
Copyright © 2016 MarketsandMarkets All Rights Reserved. This document contains highly confidential information and is the sole property of MarketsandMarkets. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of MarketsandMarkets.
DISCLAIMER: MarketsandMarkets strategic analysis services are limited publications containing valuable market information provided to a select group of customers in response to orders. Our customers acknowledge, when ordering, that MarketsandMarkets strategic analysis services are for our customers’ internal use and not for general publication or disclosure to third parties. Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation. MarketsandMarkets does not endorse any vendor, product or service depicted in its research publications. MarketsandMarkets strategic analysis publications consist of the opinions of MarketsandMarkets’ research and should not be construed as statements of fact. MarketsandMarkets disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. MarketsandMarkets takes no responsibility for any incorrect information supplied to us by manufacturers or users. All trademarks, copyrights and other forms of intellectual property belong to their respective owners and may be protected by copyright. Under no circumstance may any of these be reproduced in any form without the prior written agreement of their owner. No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers without written permission. Reproduction and/or transmission in any form and by any means including photocopying, mechanical, electronic, recording or otherwise, without the permission of the publisher is prohibited.
For information regarding permission, contact: 1-888-600-6441 sales@marketsandmarkets.com
sales@marketsandmarkets.com
www.marketsandmarkets.com
26